Notably, irisin partially alleviates endothelial dysfunction in T2DM by reducing oxidative and nitrative stress through the inhibition of NF‐κB/iNOS and PKC‐α/NADPH oxidase signalling pathways [37]. The gene discussed is PRKCA; the disease is type 2 diabetes mellitus.